prestige10qjune302007.htm

10-Q 1 prestige10qjune302007.htm PRESTIGE BRANDS HOLDINGS, INC., 10-Q FOR PERIOD ENDED JUNE 30, 2007 prestige10qjune302007.htm

U. S. SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 10-Q

[ X ]

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2007

[ ]

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ____ to _____

Commission File Number: 001-32433

PRESTIGE BRANDS HOLDINGS, INC.

(Exact name of Registrant as specified in its charter)

Delaware		20-1297589
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

90 North Broadway

Irvington, New York 10533

(Address of Principal Executive Offices, including zip code)

(914) 524-6810

(Registrant’s telephone number, including area code)

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act. (Check one):

Larger accelerated filer o Accelerated filer x Non-accelerated filer o

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12 b-2 of the Exchange Act).

Yes  No x

As of July 31, 2007, there were 50,003,321 shares of common stock outstanding.

Prestige Brands Holdings, Inc.

Form 10-Q

Index

PART I.	FINANCIAL INFORMATION

Item 1.	Consolidated Financial Statements
	Consolidated Statements of Operations – three months ended June 30, 2007
	and 2006 (unaudited)	2
	Consolidated Balance Sheets – June 30, 2007 and March 31, 2007 (unaudited)	3
	Consolidated Statement of Changes in Stockholders’ Equity and
	Comprehensive Income – three months ended June 30, 2007 (unaudited)	4
	Consolidated Statements of Cash Flows – three months ended
	June 30, 2007 and 2006 (unaudited)	5
	Notes to Unaudited Consolidated Financial Statements	6

Item 2.	Management’s Discussion and Analysis of Financial Condition
	and Results of Operations	22

Item 3.	Quantitative and Qualitative Disclosure About Market Risk	36

Item 4.	Controls and Procedures	36

PART II.	OTHER INFORMATION

Item 1.	Legal Proceedings	37

Item 1A.	Risk Factors	37

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	37

Item 6.	Exhibits	37

	Signatures

-1-

PART I

FINANCIAL INFORMATION

Item 1.

FINANCIAL STATEMENTS

Prestige Brands Holdings, Inc.

Consolidated Statements of Operations

(Unaudited)

	Three Months Ended June 30
*(In thousands, except share data)*	2007			2006
Revenues
Net sales	$	78,041		$	75,567
Other revenues		570			356
Total revenues		78,611			75,923

Costs of Sales
Costs of sales		37,322			36,325
Gross profit		41,289			39,598

Operating Expenses
Advertising and promotion		7,786			7,402
General and administrative		7,646			6,434
Depreciation		124			220
Amortization of intangible assets		2,627			2,193
Total operating expenses		18,183			16,249

Operating income		23,106			23,349

Other income (expense)
Interest income		187			185
Interest expense		(9,874	)		(9,977	)
Total other income (expense)		(9,687	)		(9,792	)

Income before income taxes		13,419			13,557

Provision for income taxes		5,099			5,301
Net income	$	8,320		$	8,256

Basic earnings per share	$	0.17		$	0.17

Diluted earnings per share	$	0.17		$	0.17

Weighted average shares outstanding:
Basic		49,660			49,372
Diluted		50,038			50,005

See accompanying notes.

-2-

Prestige Brands Holdings, Inc.

Consolidated Balance Sheets

(Unaudited)

(In thousands)

Assets	June 30, 2007			March 31, 2007
Current assets
Cash and cash equivalents	$	6,164		$	13,758
Accounts receivable		37,115			35,167
Inventories		28,510			30,173
Deferred income tax assets		2,427			2,735
Prepaid expenses and other current assets		2,419			1,935
Total current assets		76,635			83,768

Property and equipment		1,437			1,449
Goodwill		310,947			310,947
Intangible assets		654,530			657,157
Other long-term assets		9,128			10,095

Total Assets	$	1,052,677		$	1,063,416

Liabilities and Stockholders’ Equity
Current liabilities
Accounts payable	$	16,392		$	19,303
Accrued interest payable		4,609			7,552
Income taxes payable		1,144			--
Other accrued liabilities		9,146			10,505
Current portion of long-term debt		3,550			3,550
Total current liabilities		34,841			40,910

Long-term debt		443,913			459,800
Other long-term liabilities		2,801			2,801
Deferred income tax liabilities		117,126			114,571

Total Liabilities		598,681			618,082

Commitments and Contingencies – Note 13

Stockholders’ Equity
Preferred stock - $0.01 par value
Authorized – 5,000 shares
Issued and outstanding – None		--			--
Common stock - $0.01 par value
Authorized – 250,000 shares
Issued – 50,060 shares		501			501
Additional paid-in capital		379,685			379,225
Treasury stock, at cost – 57 shares at June 30, 2007 and 55 shares at March 31, 2007		(44	)		(40	)
Accumulated other comprehensive income		199			313
Retained earnings		73,655			65,335
Total stockholders’ equity		453,996			445,334

Total Liabilities and Stockholders’ Equity	$	1,052,677		$	1,063,416

See accompanying notes.

-3-

Prestige Brands Holdings, Inc.

Consolidated Statement of Changes in Stockholders’ Equity

and Comprehensive Income

Three Months Ended June 30, 2007

(Unaudited)

	Common Stock Par Shares Value				Additional Paid-in Capital		Treasury Stock Shares Amount					Accumulated Other Compre-hensive Income			Retained Earnings		Totals
*(In thousands)*
Balances - March 31, 2007		50,060	$	501	$	379,225		55	$	(40	)	$	313		$	65,335	$	445,334

Stock-based compensation		--		--		460		--		--			--			--		460

Purchase of common stock for treasury		--		--		--		2		(4	)		--			--		(4	)

Components of comprehensive income
Net income		--		--		--		--		--			--			8,320		8,320

Amortization of interest rate caps reclassified into earnings, net of income tax expense of $94		--		--		--		--		--			149			--		149

Unrealized loss on interest rate caps, net of income tax benefit of $166		--		--		--		--		--			(263	)		--		(263	)
Total comprehensive income		--		--		--		--		--			--			--		8,206

Balances – June 30, 2007		50,060	$	501	$	379,685		57	$	(44	)	$	199		$	73,655	$	453,996

See accompanying notes.

-4-

Prestige Brands Holdings, Inc.

Consolidated Statements of Cash Flows

(Unaudited)

	Three Months Ended June 30
*(In thousands)*	2007			2006
Operating Activities
Net income	$	8,320		$	8,256
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		2,751			2,413
Deferred income taxes		2,934			2,657
Amortization of deferred financing costs		780			825
Stock-based compensation		460			(9	)
Changes in operating assets and liabilities
Accounts receivable		(1,948	)		5,841
Inventories		1,663			2,471
Prepaid expenses and other current assets		(483	)		(2,181	)
Accounts payable		(2,911	)		(13	)
Income taxes payable		1,144			(17	)
Accrued liabilities		(4,302	)		1,252
Net cash provided by operating activities		8,408			21,495

Investing Activities
Purchases of equipment		(111	)		(297	)
Net cash used for investing activities		(111	)		(297	)

Financing Activities
Repayment of long-term debt		(15,887	)		(7,932	)
Purchase of common stock for treasury		(4	)		(6	)
Net cash (used for) financing activities		(15,891	)		(7,938	)

Increase (decrease) in cash		(7,594	)		13,260
Cash - beginning of period		13,758			8,200

Cash - end of period	$	6,164		$	21,460

Interest paid	$	12,036		$	11,961
Income taxes paid	$	551		$	2,609

See accompanying notes.

-5-

Prestige Brands Holdings, Inc.

Notes to Consolidated Financial Statements

(Unaudited)

1.	Business and Basis of Presentation

Nature of Business

Prestige Brands Holdings, Inc. (referred to herein as the “Company” which reference shall, unless the context requires otherwise, be deemed to refer to Prestige Brands Holdings, Inc. and all of its direct or indirect wholly-owned subsidiaries on a consolidated basis) is engaged in the marketing, sales and distribution of over-the-counter healthcare, personal care and household cleaning brands to mass merchandisers, drug stores, supermarkets and club stores primarily in the United States, Canada and certain international markets. Prestige Brands Holdings, Inc. is a holding company with no assets or operations and is also the parent guarantor of the senior revolving credit facility, senior secured term loan facility and the senior subordinated notes more fully described in Note 8 to the consolidated financial statements.

Basis of Presentation

The unaudited consolidated financial statements presented herein have been prepared in accordance with generally accepted accounting principles for interim financial reporting and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by United States generally accepted accounting principles (“GAAP”) for complete financial statements. All significant intercompany transactions and balances have been eliminated. In the opinion of management, the financial statements include all adjustments, consisting of normal recurring adjustments that are considered necessary for a fair presentation of the Company’s consolidated financial position, results of operations and cash flows for the interim periods. Operating results for the three month period ended June 30, 2007 are not necessarily indicative of results that may be expected for the year ending March 31, 2008. This financial information should be read in conjunction with the Company’s financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended March 31, 2007. References in these financial statements or notes thereto to a year (e.g. “2007”) means the Company’s fiscal quarter ended on June 30th of that year.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Although these estimates are based on the Company’s knowledge of current events and actions that the Company may undertake in the future, actual results could differ materially from those estimates. As discussed below, the Company’s most significant estimates include those made in connection with the valuation of intangible assets, sales returns and allowances, trade promotional allowances and inventory obsolescence.

Cash and Cash Equivalents

The Company considers all short-term deposits and investments with original maturities of three months or less to be cash equivalents. Substantially all of the Company’s cash is held by one bank located in Wyoming. The Company does not believe that, as a result of this concentration, it is subject to any unusual financial risk beyond the normal risk associated with commercial banking relationships.

Accounts Receivable

The Company extends non-interest bearing trade credit to its customers in the ordinary course of business. The Company maintains an allowance for doubtful accounts receivable based upon historical collection experience and expected collectibility of the accounts receivable. In an effort to reduce credit risk, the Company (i) has established credit limits for all of its customer relationships, (ii) performs ongoing credit evaluations of

-6-

customers’ financial condition, (iii) monitors the payment history and aging of customers’ receivables, and (iv) monitors open orders against an individual customer’s outstanding receivable balance.

Inventories

Inventories are stated at the lower of cost or fair value, where cost is determined by using the first-in, first-out method. The Company provides an allowance for slow moving and obsolete inventory, whereby it reduces inventories for the diminution of value, resulting from product obsolescence, damage or other issues affecting marketability, equal to the difference between the cost of the inventory and its estimated market value. Factors utilized in the determination of estimated market value include (i) current sales data and historical return rates, (ii) estimates of future demand, (iii) competitive pricing pressures, (iv) new product introductions, (v) product expiration dates, and (vi) component and packaging obsolescence.

Property and Equipment

Property and equipment are stated at cost and are depreciated using the straight-line method based on the following estimated useful lives:

	Years
Machinery	5
Computer equipment	3
Furniture and fixtures	7
Leasehold improvements	5

Expenditures for maintenance and repairs are charged to expense as incurred. When an asset is sold or otherwise disposed of, the cost and associated accumulated depreciation are removed from the accounts and the resulting gain or loss is recognized in the consolidated statement of operations.

Property and equipment are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. An impairment loss is recognized if the carrying amount of the asset exceeds its fair value.

Goodwill

The excess of the purchase price over the fair market value of assets acquired and liabilities assumed in purchase business combinations is classified as goodwill. In accordance with Financial Accounting Standards Board (“FASB”) Statement of Financial Accounting Standards (“Statement”) No. 142, “Goodwill and Other Intangible Assets,” the Company does not amortize goodwill, but performs impairment tests of the carrying value at least annually. The Company tests goodwill for impairment at the “brand” level which is one level below the operating segment level.

Intangible Assets

Intangible assets, which are composed primarily of trademarks, are stated at cost less accumulated amortization. For intangible assets with finite lives, amortization is computed on the straight-line method over estimated useful lives ranging from five to 20 years.

Indefinite lived intangible assets are tested for impairment at least annually, while intangible assets with finite lives are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. An impairment loss is recognized if the carrying amount of the asset exceeds its fair value.

Deferred Financing Costs

The Company has incurred debt issuance costs in connection with its long-term debt. These costs are capitalized as deferred financing costs and amortized using the straight-line method, which approximates the effective interest method, over the term of the related debt.

-7-

Revenue Recognition

Revenues are recognized in accordance with Securities and Exchange Commission (“SEC”) Staff Accounting Bulletin 104, “Revenue Recognition,” when the following criteria are met: (1) persuasive evidence of an arrangement exists; (2) the product has been shipped and the customer takes ownership and assumes risk of loss; (3) the selling price is fixed or determinable; and (4) collection of the resulting receivable is reasonably assured. The Company has determined that the transfer of risk of loss occurs when product is received by the customer and, accordingly, recognizes revenue at that time. Provision is made for estimated discounts related to customer payment terms and estimated product returns at the time of sale based on the Company’s historical experience.

As is customary in the consumer products industry, the Company participates in the promotional programs of its customers to enhance the sale of its products. The cost of these promotional programs varies based on the actual number of units sold during a finite period of time. The Company estimates the cost of such promotional programs at their inception based on historical experience and current market conditions and reduces sales by such estimates. These promotional programs consist of direct to consumer incentives such as coupons and temporary price reductions, as well as incentives to the Company’s customers, such as slotting fees and cooperative advertising. Estimates of the costs of these promotional programs are based on (i) historical sales experience, (ii) the current offering, (iii) forecasted data, (iv) current market conditions, and (v) communication with customer purchasing/marketing personnel. At the completion of the promotional program, the estimated amounts are adjusted to actual results.

Due to the nature of the consumer products industry, the Company is required to estimate future product returns. Accordingly, the Company records an estimate of product returns concurrent with recording sales which is made after analyzing (i) historical return rates, (ii) current economic trends, (iii) changes in customer demand, (iv) product acceptance, (v) seasonality of the Company’s product offerings, and (vi) the impact of changes in product formulation, packaging and advertising.

Costs of Sales

Costs of sales include product costs, warehousing costs, inbound and outbound shipping costs, and handling and storage costs. Shipping, warehousing and handling costs were $5.6 million and $5.7 million for 2007 and 2006, respectively.

Advertising and Promotion Costs

Advertising and promotion costs are expensed as incurred. Slotting fees associated with products are recognized as a reduction of sales. Under slotting arrangements, the retailers allow the Company’s products to be placed on the stores’ shelves in exchange for such fees. Direct reimbursements of advertising costs are reflected as a reduction of advertising costs in the period earned.

Stock-based Compensation

During fiscal 2006, the Company adopted FASB, Statement No. 123(R), “Share-Based Payment” (“Statement No. 123(R)”) with the grants of restricted stock and options to purchase common stock to employees and directors in accordance with the provisions of the Company’s 2005 Long-Term Equity Incentive Plan (the “Plan”). Statement No. 123(R) requires the Company to measure the cost of services to be rendered based on the grant-date fair value of the equity award. Compensation expense is to be recognized over the period an employee is required to provide service in exchange for the award, generally referred to as the requisite service period. The Company recorded stock-based compensation charges of $460,000 during 2007, while during 2006, the Company recorded a net non-cash compensation credit of $9,000 due to the reversal of compensation charges in the amount of $142,000 associated with the departure of a former member of management.

Income Taxes

Income taxes are recorded in accordance with the provisions of FASB Statement No. 109, “Accounting for Income Taxes” (“Statement No. 109”). Pursuant to Statement No. 109, deferred tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is established when necessary to reduce deferred tax assets to the amounts expected to be realized.

-8-

In June 2006, the FASB issued FASB Interpretation No. 48, “Accounting for Uncertainty in Income Taxes--an interpretation of FASB Statement 109” (“FIN 48”), which clarifies the accounting for uncertainty in income taxes recognized in a company’s financial statements in accordance with Statement No. 109. FIN 48 prescribes a recognition threshold and measurement attributes for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. As a result, the Company has applied a more-likely-than-not recognition threshold for all tax uncertainties. FIN 48 only allows the recognition of those tax benefits that have a greater than 50% likelihood of being sustained upon examination by the various taxing authorities. The adoption of FIN 48, effective April 1, 2007, did not result in a cumulative effect adjustment to the opening balance of retained earnings or adjustment to any of the components of assets, liabilities or equity in the consolidated balance sheet.

The Company is subject to taxation in the US, various state and foreign jurisdictions. The Company remains subject to examination by tax authorities for years after 2003.

The Company classifies penalties and interest related to unrecognized tax benefits as income tax expense in the Statement of Operations.

Derivative Instruments

FASB Statement No. 133, “Accounting for Derivative Instruments and Hedging Activities” (“Statement No. 133”), requires companies to recognize derivative instruments as either assets or liabilities in the balance sheet at fair value. The accounting for changes in the fair value of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and further, on the type of hedging relationship. For those derivative instruments that are designated and qualify as hedging instruments, a company must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, a cash flow hedge or a hedge of a net investment in a foreign operation.

The Company has designated its derivative financial instruments as cash flow hedges because they hedge exposure to variability in expected future cash flows that are attributable to interest rate risk. For these hedges, the effective portion of the gain or loss on the derivative instrument is reported as a component of other comprehensive income (loss) and reclassified into earnings in the same line item associated with the forecasted transaction in the same period or periods during which the hedged transaction affects earnings. Any ineffective portion of the gain or loss on the derivative instruments is recorded in results of operations immediately.

Earnings Per Share

Basic earnings per share is calculated based on income available to common stockholders and the weighted-average number of shares outstanding during the reporting period. Diluted earnings per share is calculated based on income available to common stockholders and the weighted-average number of common and potential common shares outstanding during the reporting period. Potential common shares, composed of the incremental common shares issuable upon the exercise of stock options, stock appreciation rights and unvested restricted shares, are included in the earnings per share calculation to the extent that they are dilutive.

Fair Value of Financial Instruments

The carrying value of cash, accounts receivable and accounts payable at both June 30, 2007 and March 31, 2007 approximates fair value due to the short-term nature of these instruments. The carrying value of long-term debt at both June 30, 2007 and March 31, 2007 approximates fair value based on interest rates for instruments with similar terms and maturities.

Recently Issued Accounting Standards

In February 2007, the FASB issued SFAS No. 159, “The Fair Value Option for Financial Assets and Financial Liabilities - Including an amendment of FASB Statement No. 115” (“Statement No. 159”). Statement No. 159 permits companies to choose to measure certain financial instruments and certain other items at fair value. Unrealized gains and losses on items for which the fair value option has been elected will be recognized in earnings at each subsequent reporting date. Statement No. 159 is effective for the Company’s interim financial statements issued after April 1, 2008. The Company is evaluating the impact that the adoption of Statement No. 159 will have on its consolidated financial statements.

-9-

In September 2006, the FASB issued SFAS No. 157, “Fair Value Measurements” (“Statement No. 157”) to address inconsistencies in the definition and determination of fair value pursuant to GAAP. Statement No. 157 provides a single definition of fair value, establishes a framework for measuring fair value in GAAP and expands disclosures about fair value measurements in an effort to increase comparability related to the recognition of market-based assets and liabilities and their impact on earnings. Statement No. 157 is effective for the Company’s interim financial statements issued after April 1, 2008. The Company is evaluating the impact that the adoption of Statement No. 157 will have on its consolidated financial statements.

Management has reviewed and continues to monitor the actions of the various financial and regulatory reporting agencies and is currently not aware of any other pronouncement that could have a material impact on the Company’s consolidated financial position, results of operations or cash flows.

2.	Accounts Receivable

Accounts receivable consist of the following (in thousands):

	June 30, 2007			March 31, 2007

Accounts receivable	$	37,645		$	35,274
Other receivables		1,170			1,681
		38,815			36,955
Less allowances for discounts, returns and uncollectible accounts		(1,700	)		(1,788	)

	$	37,115		$	35,167

3.	Inventories

Inventories consist of the following (in thousands):

	June 30, 2007		March 31, 2007

Packaging and raw materials	$	2,931	$	2,842
Finished goods		25,579		27,331

	$	28,510	$	30,173

Inventories are shown net of allowances for obsolete and slow moving inventory of $710,000 and $1.8 million at June 30, 2007 and March 31, 2007, respectively.

-10-

4.	Property and Equipment

Property and equipment consist of the following (in thousands):

	June 30, 2007			March 31, 2007

Machinery	$	1,572		$	1,480
Computer equipment		585			566
Furniture and fixtures		247			247
Leasehold improvements		372			372
		2,776			2,665

Accumulated depreciation		(1,339	)		(1,216	)

	$	1,437		$	1,449

5.	Goodwill

A reconciliation of the activity affecting goodwill by operating segment is as follows (in thousands):

	Over-the-Counter Healthcare		Household Cleaning		Personal Care		Consolidated

Balance – March 31, 2007	$	235,647	$	72,549	$	2,751	$	310,947

Additions		--		--		--		--

Balance – June 30, 2007	$	235,647	$	72,549	$	2,751	$	310,947

6.	Intangible Assets

A reconciliation of the activity affecting intangible assets is as follows (in thousands):

	Indefinite Lived Trademarks		Finite Lived Trademarks		Non Compete Agreement		Totals
*Carrying Amounts*
Balance – March 31, 2007	$	544,963	$	139,470	$	196	$	684,629

Additions		--		--		--		--

Balance – June 30, 2007	$	544,963	$	139,470	$	196	$	684,629

*Accumulated Amortization*
Balance – March 31, 2007	$	--	$	27,375	$	97	$	27,472

Additions		--		2,616		11		2,627

Balance – June 30, 2007	$	--	$	29,991	$	108	$	30,099

-11-

At June 30, 2007, intangible assets are expected to be amortized over a period of five to 30 years as follows (in thousands):

Year Ending June 30
2008	$	10,507
2009		10,150
2010		9,078
2011		9,071
2012		9,071
Thereafter		61,690

	$	109,567

7.	Other Accrued Liabilities

Other accrued liabilities consist of the following (in thousands):

	June 30, 2007		March 31, 2007

Accrued marketing costs	$	5,830	$	5,687
Accrued payroll		2,147		3,721
Accrued commissions		397		335
Other		772		762

	$	9,146	$	10,505

-12-

8.	Long-Term Debt

Long-term debt consists of the following (in thousands):

	June 30, 2007			March 31, 2007

Senior revolving credit facility (“Revolving Credit Facility”), which expires on April 6, 2009 and is available for maximum borrowings of up to $60.0 million. The Revolving Credit Facility bears interest at the Company’s option at either the prime rate plus a variable margin or LIBOR plus a variable margin. The variable margins range from 0.75% to 2.50% and at June 30, 2007, the interest rate on the Revolving Credit Facility was 9.5% per annum. The Company is also required to pay a variable commitment fee on the unused portion of the Revolving Credit Facility. At June 30, 2007, the commitment fee was 0.50% of the unused line. The Revolving Credit Facility is collateralized by substantially all of the Company’s assets.	$	--		$	--

Senior secured term loan facility (“Tranche B Term Loan Facility” and together with the Revolving Credit Facility, the “Senior Credit Facility”) that bears interest at the Company’s option at either the prime rate plus a margin of 1.25% or LIBOR plus a margin of 2.25%. At June 30, 2007, the applicable interest rate on the Tranche B Term Loan Facility was 7.63%. Principal payments of $887,500 plus accrued interest are payable quarterly. At June 30, 2007, the Company may borrow up to a maximum amount of $200.0 million under the Tranche B Term Loan Facility. Current amounts outstanding under the Tranche B Term Loan Facility mature on April 6, 2011, while any additional amounts borrowed will mature on October 6, 2011. The Tranche B Term Loan Facility is collateralized by substantially all of the Company’s assets.		321,463			337,350

Senior Subordinated Notes that bear interest at 9.25% which is payable on April 15^th and October 15^th of each year. The Senior Subordinated Notes mature on April 15, 2012; however, the Company may redeem some or all of the Senior Subordinated Notes on or prior to April 15, 2008 at a redemption price equal to 100% plus a make-whole premium, and after April 15, 2008, at redemption prices set forth in the Indenture governing the Senior Subordinated Notes. The Senior Subordinated Notes are unconditionally guaranteed by Prestige Brands Holdings, Inc., and its domestic wholly-owned subsidiaries other than Prestige Brands, Inc., the issuer. Each of these guarantees is joint and several. There are no significant restrictions on the ability of any of the guarantors to obtain funds from their subsidiaries.		126,000			126,000

		447,463			463,350
Current portion of long-term debt		(3,550	)		(3,550	)

	$	443,913		$	459,800

Effective as of December 19, 2006: (i) a Second Supplemental Indenture (“Second Supplemental Indenture”), and (ii) a Guaranty Supplement (“Indenture Guaranty Supplement”) were entered into with the trustee for the holders

-13-

of the Senior Subordinated Notes. The Second Supplemental Indenture supplements and amends the Indenture, dated as of April 6, 2004, as supplemented on October 6, 2004 (“Indenture”). Pursuant to the terms of the Second Supplemental Indenture and the Indenture Guaranty Supplement, the Company agreed to guaranty all of the obligations of Prestige Brands, Inc., an indirect wholly-owned subsidiary of the Company (“PBI”), set forth in the Indenture governing PBI’s Senior Subordinated Notes. The Second Supplemental Indenture also amended the covenant requiring Prestige Brands International, LLC (“Prestige Brands International”), an indirect wholly-owned subsidiary of the Company, to file periodic reports with the SEC pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended (“Exchange Act”). So long as the Company or any other guarantor is required to file periodic reports under Section 13 or 15(d) of the Exchange Act that are substantially the same as the periodic reports that Prestige Brands International would otherwise be required to file with the SEC pursuant to the Indenture, Prestige Brands International is not required to file such reports.

Also effective as of December 19, 2006, a Joinder Agreement (“Joinder Agreement”) and a Guaranty Supplement (“Credit Agreement Guaranty Supplement”) were entered into with the administrative agent for the lenders under the Senior Credit Facility. Pursuant to the terms of the Joinder Agreement and the Credit Agreement Guaranty Supplement, the Company agreed to become a party to the Pledge and Security Agreement (“Security Agreement”) and the Guaranty (“Credit Agreement Guaranty”), each dated as of April 6, 2004, by PBI and certain of its affiliates in favor of the lenders. The Security Agreement and the Credit Agreement Guaranty secure the performance by PBI of its obligations under the Credit Agreement, dated as of April 6, 2004, as amended (“Credit Agreement”), by granting security interests to PBI’s lenders in collateral owned by the Company and certain of its subsidiaries and providing guaranties of such obligations by certain of PBI’s affiliates.

The Senior Credit Facility contains various financial covenants, including provisions that require the Company to maintain certain leverage ratios, interest coverage ratios and fixed charge coverage ratios. The Senior Credit Facility and the Senior Subordinated Notes also contain provisions that restrict the Company from undertaking specified corporate actions, such as asset dispositions, acquisitions, dividend payments, repurchase of common shares outstanding, changes of control, incurrence of indebtedness, creation of liens, making of loans and transactions with affiliates. Additionally, the Senior Credit Facility and the Senior Subordinated Notes contain cross-default provisions whereby a default pursuant to the terms and conditions of either indebtedness will cause a default on the remaining indebtedness. At June 30, 2007, the Company was in compliance with its applicable financial and other covenants under the Senior Credit Facility and the Indenture.

Future principal payments required in accordance with the terms of the Senior Credit Facility and the Senior Subordinated Notes are as follows (in thousands):

Year Ending June 30
2008	$	3,550
2009		3,550
2010		3,550
2011		3,550
2012		307,263
Thereafter		126,000

	$	447,463

In an effort to mitigate the impact of changing interest rates, the Company entered into interest rate cap agreements with various financial institutions. In June 2004, the Company purchased a 5% interest rate cap with a notional amount of $20.0 million which expired in June 2006. In March 2005, the Company purchased interest rate cap agreements with a total notional amount of $180.0 million and cap rates ranging from 3.25% to 3.75%. On May 31, 2006, an interest rate cap agreement with a notional amount of $50.0 million and a 3.25% cap rate expired. Additionally, an interest rate cap agreement with a notional amount of $80.0 million and a 3.50% cap rate expired on May 30, 2007. The remaining agreement, with a notional amount of $50.0 million and a cap rate of 3.75%, terminates on May 30, 2008. The Company is accounting for the interest rate cap agreements as cash flow hedges. The fair values of the interest rate cap agreements, which are included in other long-term assets, were $767,000 and $1.2 million at June 30, 2007 and March 31, 2007, respectively.

-14-

9.	Stockholders’ Equity

The Company is authorized to issue 250.0 million shares of common stock, $0.01 par value per share, and 5.0 million shares of preferred stock, $0.01 par value per share. The Board of Directors may direct the issuance of the undesignated preferred stock in one or more series and determine preferences, privileges and restrictions thereof.

Each share of common stock has the right to one vote on all matters submitted to a vote of stockholders. The holders of common stock are also entitled to receive dividends whenever funds are legally available and when declared by the Board of Directors, subject to prior rights of holders of all classes of stock outstanding having priority rights as to dividends. No dividends have been declared or paid on the Company’s common stock through June 30, 2007.

10.

Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share (in thousands):

	Three Months Ended June 30
	2007		2006
Numerator
Net income	$	8,320	$	8,256

Denominator
Denominator for basic earnings per share – weighted average shares		49,660		49,372

Dilutive effect of unvested restricted common stock, options and stock appreciation rights issued to employees and directors		378		633

Denominator for diluted earnings per share		50,038		50,005

Earnings per Common Share:
Basic	$	0.17	$	0.17

Diluted	$	0.17	$	0.17

At June 30, 2007, 287,000 shares of restricted stock issued to management and employees are unvested and excluded from the calculation of basic earnings per share; however, such shares are included in the calculation of diluted earnings per share. At June 30, 2007, 159,000 shares of restricted stock granted to management and employees, subject only to time vesting requirements, have been excluded from basic earnings per share; however, such shares are included in the calculation of diluted earnings per share. Additionally, 382,000 shares of restricted stock granted to management and employees, as well as 16,000 stock appreciation rights have been excluded from the calculation of both basic and diluted earnings per share since vesting of such shares is subject to contingencies, while options to purchase 255,000 shares of common stock have been excluded from diluted earnings per shares because their inclusion would be anti-dilutive.

At June 30, 2006, 570,000 shares of restricted stock issued to management and employees were unvested and excluded from the calculation of basic earnings per share; however, such shares are included in the calculation of diluted earnings per share. Additionally, at June 30, 2006, 146,000 shares of restricted stock granted to management and employees have been excluded from the calculation of both basic and diluted earnings per share since vesting of such shares is subject to contingencies.

-15-

11.

Share-Based Compensation

In connection with the Company’s initial public offering, the Board of Directors adopted the 2005 Long-Term Equity Incentive Plan (“Plan”) which provides for the grant, to a maximum of 5.0 million shares, of stock options, restricted stock units, deferred stock units and other equity-based awards. Directors, officers and other employees of the Company and its subsidiaries, as well as others performing services for the Company, are eligible for grants under the Plan. The Company believes that such awards better align the interests of its employees with those of its stockholders.

During 2006, the Company adopted Statement No. 123(R) with the initial grants of restricted stock and options to purchase common stock to employees and directors in accordance with the provisions of the Plan. During 2007, the Company recorded compensation costs and related tax benefits of $460,000 and $175,000, respectively, while during 2006, the Company recorded a credit to income of $9,000 due to the reversal of compensation costs in connection with the departure of a former member of management. No restricted shares were issued in 2006.

Restricted Shares

Restricted shares granted under the plan generally vest in 3 to 5 years, contingent on attainment of Company performance goals, including both revenue and earnings per share growth targets or time vesting as determined by the Compensation Committee of the Board of Directors. Certain restricted share awards provide for accelerated vesting if there is a change of control. The fair value of nonvested restricted shares is determined as the closing price of the Company’s common stock on the day preceding the grant date. The weighted-average grant-date fair values during 2007 were $12.52.

A summary of the Company’s restricted shares granted under the Plan is presented below:

Restricted Shares	Shares (000)			Weighted-Average Grant-Date Fair Value

Nonvested at March 31, 2006		198.0		$	12.32
Granted		--			--
Vested		--			--
Forfeited		(34.5	)		12.89
Nonvested at June 30, 2006		163.5		$	12.20

Nonvested at March 31, 2007		294.4		$	11.05
Granted		264.0			12.52
Vested		--			--
Forfeited		(17.2	)		11.19
Nonvested at June 30, 2007		541.2		$	11.76

Options

The Plan provides that the exercise price of the option granted shall be no less than the fair market value of the Company’s common stock on the date the option is granted. Options granted have a term of no greater than 10 years from the date of grant and vest in accordance with a schedule determined at the time the option is granted, generally 3 to 5 years. Certain option awards provide for accelerated vesting if there is a change in control.

The fair value of each option award is estimated on the date of grant using the Black-Scholes Option Pricing Model (“Black-Scholes Model”) that uses the assumptions noted in the following table. Expected volatilities are based on the historical volatility of the Company’s common stock and other factors, including the historical volatilities of comparable companies. The Company uses appropriate historical data, as well as current data, to estimate option exercise and employee termination behaviors. Employees that are expected to exhibit similar exercise or termination behaviors are grouped together for the purposes of valuation. The expected terms of the

-16-

options granted are derived from management’s estimates and information derived from the public filings of companies similar to the Company and represent the period of time that options granted are expected to be outstanding. The risk-free rate represents the yield on U.S. Treasury bonds with a maturity equal to the expected term of the granted option. The weighted-average grant-date fair value of the options granted during 2007 was $12.86. There were no options granted during 2006.

	2007			2006
Expected volatility		33.2	%		--
Expected dividends		--			--
Expected term in years		6.0			--
Risk-free rate		4.5	%		--

A summary of option activity under the Plan is as follows:

Options	Shares (000)			Weighted-Average Exercise Price		Weighted- Average Remaining Contractual Term

Outstanding at March 31, 2006		61.8		$	12.95		4.3
Granted		--			--		--
Exercised		--			--		--
Forfeited or expired		(61.8	)		12.95		--
Outstanding at June 30, 2006		--		$	--		--

Outstanding at March 31, 2007		--		$	--		--
Granted		255.1			12.86		10.0
Exercised		--			--		--
Forfeited or expired		--			--		--
Outstanding at June 30, 2007		255.1		$	12.86		10.0

Exercisable at June 30, 2007		--		$	--		--

Stock Appreciation Rights (“SARS”)

The Plan provides that the issuance price of a SAR shall be no less than the market price of the Company’s common stock on the date the SAR is granted. SARS may be granted with a term of no greater than 10 years from the date of grant and will vest in accordance with a schedule determined at the time the SAR is granted, generally 3 to 5 years. The Board of Directors, in its sole discretion, may settle the Company’s obligation to the executive in shares of the Company’s common stock, cash, other securities of the Company or any combination thereof. The weighted-average grant date fair value of the SARS granted during 2007 was $3.68. The fair value of each SAR award was estimated on the date of grant using the Black-Scholes Model using the assumptions noted in the following table.

	2007	2006
Expected volatility	--	50.0%
Expected dividends	--	--
Expected term in years	--	2.8
Risk-free rate	--	5.0%

-17-

A summary of SARS activity under the Plan is as follows:

SARS	Shares (000)		Grant Date Stock Price		Weighted- Average Remaining Contractual Term

Outstanding at March 31, 2007		16.1	$	9.97		2.0
Granted		--		--		--
Forfeited or expired		--		--		--
Outstanding at June 30, 2007		16.1	$	9.97		1.75

Exercisable at June 30, 2007		--	$	--		--

At June 30, 2007 and March 31, 2007, there were $5.2 million and $1.4 million, respectively, of unrecognized compensation costs related to nonvested share-based compensation arrangements under the Plan based on management’s estimate of the shares that will ultimately vest. The Company expects to recognize such costs over the next 3.0 years. However, certain of the restricted shares vest upon the attainment of Company performance goals and if such goals are not met, no compensation costs would ultimately be recognized and any previously recognized compensation cost would be reversed. At June 30, 2007, there were 4.2 million shares available for issuance under the Plan.

12.

Income Taxes

Income taxes are recorded in the Company’s quarterly financial statements based on the Company’s estimated annual effective income tax rate. The effective tax rates used in the calculation of income taxes were 38.0% and 39.1% for 2007 and 2006, respectively. The reduction in the income tax rates results from the implementation of initiatives to obtain operational, as well as tax, efficiencies during the fiscal year ended March 31, 2007.

At June 30, 2007, Medtech Products Inc., a wholly-owned subsidiary of the Company, had a net operating loss carryforward of approximately $2.6 million which may be used to offset future taxable income of the consolidated group and which begins to expire in 2020. The net operating loss carryforward is subject to an annual limitation as to usage under Internal Revenue Code Section 382 of approximately $240,000.

13.

Commitments and Contingencies

The legal proceedings in which we are involved have been disclosed previously in our Annual Report on Form 10-K for the fiscal year ended March 31, 2007. The following disclosure contains recent developments in our pending legal proceedings and should be read in conjunction with the legal proceedings disclosure contained in Part I, Item 3 of our Annual Report on Form 10-K for the fiscal year ended March 31, 2007.

OraSure Technologies Litigation

On July 12, 2007, the Appellate Division of the Supreme Court of the State of New York issued an Order affirming the Order of the Supreme Court of the State of New York which denied OraSure Technologies’ petition for a preliminary injunction that would have prohibited the Company from selling cryogenic wart removal products under the Wartner® brand. In addition, the Appellate Division dismissed OraSure Technologies’ appeal from the Supreme Court’s Order which denied OraSure Technologies’ motion for reargument. Based on the foregoing, the Appellate Division held that a preliminary injunction was not an appropriate remedy in the action and recalled and vacated its Order dated May 17, 2007, which granted a preliminary injunction. An arbitration hearing is scheduled to be held in August 2007.

The Company is also involved from time to time in other routine legal matters and other claims incidental to its business. The Company reviews outstanding claims and proceedings internally and with external counsel as necessary to assess probability and amount of potential loss. These assessments are re-evaluated at each reporting period and as new information becomes available to determine whether a reserve should be established or if any existing reserve should be adjusted. The actual cost of resolving a claim or proceeding ultimately may be substantially different than the amount of the recorded reserve. In addition, because it is not permissible under generally accepted accounting principles to establish a litigation reserve until the loss is both probable and estimable, in some cases there may be insufficient time to establish a reserve prior to the actual incurrence of the loss (upon verdict and judgment at trial, for example, or in the case of a quickly negotiated settlement). The Company believes the resolution of routine matters and other incidental claims, taking into account reserves and insurance, will not have a material adverse effect on its business, financial condition or results from operations.

-18-

Lease Commitments

The Company has operating leases for office facilities and equipment in New York, New Jersey and Wyoming, which expire at various dates through 2011.

The following summarizes future minimum lease payments for the Company’s operating leases (in thousands):

	Facilities		Equipment		Total
Year Ending June 30,
2008	$	650	$	122	$	772
2009		514		106		620
2010		11		87		98
2011		--		6		6

	$	1,175	$	321	$	1,496

Rent expense for 2007 and 2006 was $152,000 and $138,700, respectively.

14.

Concentrations of Risk

The Company’s sales are concentrated in the areas of over-the-counter healthcare, household cleaning and personal care products. The Company sells its products to mass merchandisers, food and drug accounts, and dollar and club stores. During 2007 and 2006, approximately 56.5%, and 59.2%, respectively, of the Company’s total sales were derived from its four major brands. During 2007 and 2006, approximately 24.9% and 25.2%, respectively, of the Company’s net sales were made to one customer. At June 30, 2007, approximately 21.9% of accounts receivable were owed by the same customer.

The Company manages product distribution in the continental United States through a main distribution center in St. Louis, Missouri. A serious disruption, such as a flood or fire, to the main distribution center could damage the Company’s inventories and could materially impair the Company’s ability to distribute its products to customers in a timely manner or at a reasonable cost. The Company could incur significantly higher costs and experience longer lead times associated with the distribution of its products to its customers during the time that it takes the Company to reopen or replace its distribution center. As a result, any such disruption could have a material adverse affect on the Company’s sales and profitability.

The Company has relationships with over 40 third-party manufacturers. Of those, the top 10 manufacturers produced items that accounted for approximately 78% of the Company’s gross sales for 2007. The Company does not have long-term contracts with 3 of these manufacturers and certain manufacturers of various smaller brands, which collectively, represented approximately 35% of the Company’s gross sales for 2007. The lack of manufacturing agreements for these products exposes the Company to the risk that a manufacturer could stop producing the Company’s products at any time, for any reason or fail to provide the Company with the level of products the Company needs to meet its customers’ demands. Without adequate supplies of merchandise to sell to the Company’s customers, sales would decrease materially and the Company’s business would suffer.

15.

Business Segments

Segment information has been prepared in accordance with FASB Statement No. 131, “Disclosures about Segments of an Enterprise and Related Information.” The Company’s operating and reportable segments consist of (i) Over-the-Counter Healthcare, (ii) Household Cleaning and (iii) Personal Care.

There were no inter-segment sales or transfers during any of the periods presented. The Company evaluates the performance of its operating segments and allocates resources to them based primarily on contribution margin.

-19-

The table below summarizes information about the Company’s operating and reportable segments (in thousands).

	Three Months Ended June 30, 2007
	Over-the-Counter		Household		Personal
	Healthcare		Cleaning		Care		Consolidated

Net sales	$	42,426	$	29,345	$	6,270	$	78,041
Other revenues		--		542		28		570

Total revenues		42,426		29,887		6,298		78,611
Cost of sales		15,386		18,393		3,543		37,322

Gross profit		27,040		11,494		2,755		41,289
Advertising and promotion		5,881		1,628		277		7,786

Contribution margin	$	21,159	$	9,866	$	2,478		33,503
Other operating expenses								10,397

Operating income								23,106
Other (income) expense								9,687
Provision for income taxes								5,099

Net income							$	8,320

	Three Months Ended June 30, 2006
	Over-the-Counter		Household		Personal
	Healthcare		Cleaning		Care		Consolidated

Net sales	$	39,598	$	29,738	$	6,231	$	75,567
Other revenues				356		--		356

Total revenues		39,598		30,094		6,231		75,923
Cost of sales		14,397		18,154		3,774		36,325

Gross profit		25,201		11,940		2,457		39,598
Advertising and promotion		5,426		1,689		287		7,402

Contribution margin	$	19,775	$	10,251	$	2,170		32,196
Other operating expenses								8,847

Operating income								23,349
Other (income) expense								9,792
Provision for income taxes								5,301

Net income							$	8,256

During 2007 and 2006, approximately 95.3% and 96.1%, respectively, of the Company’s sales were made to customers in the United States and Canada. At June 30, 2007, substantially all of the Company’s long-term assets

-20-

were located in the United States of America and have been allocated to the operating segments as follows:

	Over-the-Counter		Household		Personal
	Healthcare		Cleaning		Care		Consolidated

Goodwill	$	235,647	$	72,549	$	2,751	$	310,947

Intangible assets
Indefinite lived		374,070		170,893		--		544,963
Finite lived		92,881		18		16,668		109,567
		466,951		170,911		16,668		654,530

	$	702,598	$	243,460	$	19,419	$	965,477

-21-

ITEM 2.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion of our financial condition and results of operations should be read together with the consolidated financial statements and the related notes included in our Annual Report on Form 10-K for the fiscal year ended March 31, 2007. This discussion and analysis may contain forward-looking statements that involve certain risks, assumptions and uncertainties. Future results could differ materially from the discussion that follows for many reasons, including the factors described in Part I, Item 1A., “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended March 31, 2007, as well as those described in future reports filed with the SEC. See also “Cautionary Statements Regarding Forward Looking Statements” on page 35 of this Quarterly Report on Form 10-Q.

General

We are engaged in the marketing, sales and distribution of brand name over-the-counter healthcare, household cleaning and personal care products to mass merchandisers, drug stores, supermarkets and club stores primarily in the United States and Canada. We operate in niche segments of these categories where we can use the strength of our brands, our established retail distribution network, a low-cost operating model and our experienced management team as a competitive advantage to grow our presence in these categories and, as a result, grow our sales and profits.

We have grown our brand portfolio by acquiring strong and well-recognized brands from larger consumer products and pharmaceutical companies, as well as other brands from smaller private companies. While the brands we have purchased from larger consumer products and pharmaceutical companies have long histories of support and brand development, we believe that at the time we acquired them they were considered “non-core” by their previous owners and did not benefit from the focus of senior level management or strong marketing support. We believe that the brands we have purchased from smaller private companies have been constrained by the limited resources of their prior owners. After acquiring a brand, we seek to increase its sales, market share and distribution in both existing and new channels. We pursue this growth through increased spending on advertising and promotion, new marketing strategies, improved packaging and formulations and innovative new products.

In October 2005, we completed the acquisition of the “Chore Boy®” brand of cleaning pads and sponges. The purchase price of this acquisition was $22.6 million, including direct costs of $400,000. We purchased the Chore Boy brand with funds generated from operations.

In November 2005, we completed the acquisition of Dental Concepts LLC, a marketer of therapeutic oral care products sold under “The Doctor’s®” brand. The purchase price of the ownership interests was approximately $30.2 million, including fees and expenses of the acquisition of $1.3 million. We financed the acquisition price through the utilization of our Revolving Credit Facility in the amount of $30.0 million and cash on hand.

In September 2006, we completed the acquisition of Wartner USA B.V., a privately held Netherlands limited liability company, which owned the intellectual property associated with the “Wartner®” brand of over-the-counter wart treatment products. The purchase price of this acquisition was $31.2 million, inclusive of direct costs of the acquisition of $216,000. We purchased the Wartner brand with funds generated from operations and the assumption of approximately $5.0 million of contingent payments to the former owner of the Wartner brand.

-22-

Three Month Period Ended June 30, 2007 compared to the

Three Month Period Ended June 30, 2006

Revenues

	2007 Revenues %			2006 Revenues %			Increase (Decrease) %

OTC Healthcare	$	42,426	54.0	$	39,598	52.2	$	2,828		7.1
Household Cleaning		29,887	38.0		30,094	39.6		(207	)	(0.7	)
Personal Care		6,298	8.0		6,231	8.2		67		1.1

	$	78,611	100.0	$	75,923	100.0	$	2,688		3.5

Revenues for the three month period ended June 30, 2007 increased $2.7 million, or 3.5%, versus 2006, primarily as a result of the acquisition of the Wartner brand, acquired in September of 2006. Excluding the impact the Wartner acquisition, revenues were down 0.5%.

Over-the-Counter Healthcare Segment

Revenues of the Over-the-Counter Healthcare segment increased by $2.8 million, or 7.1%, for 2007 versus 2006. The increase was primarily due to the acquisition of the Wartner brand in September 2006. Excluding the impact of this acquisition, revenues were down 0.7% for the period. Revenue increases for Compound W®, Little Remedies®, Murine®, New Skin® and Dermoplast® were offset by revenue decreases for the Chloraseptic®, Clear eyes®, and The Doctor’s brands. The Compound W revenue increase was primarily the result of a change in the timing of promotional shipments in the current period which shipped a quarter earlier in the previous calendar year. Little Remedies’ revenue increased during the period primarily as a result of strong consumer consumption. Murine’s revenue increased as a result of the launch of Earigate^TM, the new item that helps prevent earwax build-up with its patented reverse spray technology. New Skin’s revenue increase is due to higher consumer consumption. The Dermoplast revenue increase is primarily a result of increased distribution of its Poison Ivy Treatment product. The Clear eyes sales decline is a result of strong pipeline sales of new items during the prior year period. The Doctor’s brand revenue decline is a result of slowing consumer consumption of The Doctor’s Nightguard^TM dental protector which resulted from competitive entries into the bruxism category during the quarter.

Household Cleaning Segment

Revenues of the Household Cleaning segment declined 1% for 2007 versus the comparable period in 2006, as a result of sales declines of Chore Boy, partially offset by modest revenue increases of Comet® and Spic and Span® brands. Chore Boy revenues were below very strong prior year period sales which benefited from strong distributor purchases in advance of a price increase. Comet revenue increased as a result of Comet Spray Gel which was launched in the prior fiscal quarter. Spic and Span’s revenue increase was primarily the result of new distribution of the antibacterial spray item in the second half of fiscal year 2007.

Personal Care Segment

Revenues of the Personal Care segment experienced a slight increase for 2007 versus the comparable period in 2006. The increase in revenue is attributable to the Cutex®, Denorex® and Prell® brands. Cutex revenue increased slightly as a result of the new “pump” bottle product. Denorex shipments decreased during the period, however, net revenues increased due to lower product returns from trade customers compared to the comparable period of 2006. Prell’s revenue increased in line with consumer consumption.

-23-

Gross Profit

	2007 Gross Profit %			2006 Gross Profit %			Increase (Decrease) %

OTC Healthcare	$	27,040	63.7	$	25,201	63.6	$	1,839		7.3
Household Cleaning		11,494	38.5		11,940	39.7		(446	)	(3.7	)
Personal Care		2,755	43.7		2,457	39.4		298		12.1

	$	41,289	52.5	$	39,598	52.2	$	1,691		4.3

Gross profit for 2007 increased by $1.7 million, or 4.3%, versus 2006. As a percent of total revenue, gross profit increased from 52.2% in 2006 to 52.5% during 2007. The increase in gross profit percentage was primarily the result of a shift in sales to the higher margin OTC Healthcare segment.

Over-the-Counter Healthcare Segment

Gross profit of the Over-the-Counter Healthcare segment increased $1.8 million, or 7.3%, for 2007 versus 2006. As a percent of OTC revenue, gross profit increased from 63.6% for 2006 to 63.7% during 2007. The slight increase in gross profit percentage was primarily the result of lower inventory obsolescence costs.

Household Cleaning Segment

Gross profit of the Household Cleaning segment decreased by $446,000, or 3.7%, for 2007 versus 2006. As a percent of household cleaning revenue, gross profit decreased from 39.7% for 2006 to 38.5% during 2007. The decrease in gross profit percentage is primarily a result of higher product costs partially offset by lower distribution costs.

Personal Care Segment

Gross profit of the Personal Care segment increased $298,000, or 12.1%, for 2007 versus 2006. As a percent of personal care revenue, gross profit increased from 39.4% for 2006 to 43.7% during 2007. The increase in gross profit percentage was primarily a result lower product returns and a reduction in promotional pricing allowances.

Contribution Margin

	2007 Contribution Margin %			2006 Contribution Margin %			Increase (Decrease) %

OTC Healthcare	$	21,159	49.9	$	19,775	49.9	$	1,384		7.0
Household Cleaning		9,866	33.0		10,251	34.1		(385	)	(3.8	)
Personal Care		2,478	39.3		2,170	34.8		308		14.2

	$	33,503	42.6	$	32,196	42.4	$	1,307		4.1

Contribution margin, defined as gross profit less advertising and promotional expenses, for 2007 increased $1.3 million, or 4.1%, for 2007 versus 2006. The contribution margin increase was a result of the increase in sales and gross profit as previously discussed, partially offset by a $400,000, or 3.7% increase in advertising and promotional spending. The increase was primarily attributable to the Over-the-Counter Healthcare segment.

Over-the-Counter Healthcare Segment

Contribution margin for the Over-the-Counter Healthcare segment increased by $1.4 million, or 7.0%, for 2007 versus 2006. The contribution margin increase was a result of the increase in sales and gross profit as previously discussed, partially offset by a $400,000, or an 8.4% increase in advertising and promotional spending. The increase in advertising and promotional spending was primarily a result of increased television media behind The Doctor’s Nightguard^TM and Compound W brands.

-24-

Household Cleaning Segment

Contribution margin for the Household Cleaning segment decreased by $385,000, or 3.8%, for 2007 versus 2006. The contribution margin decrease was a result of the decrease in sales and gross profit as previously discussed, partially offset by a $61,000, or a 3.6% reduction in advertising and promotional spending. The decrease was a result of a modest reduction of promotional spending behind the Chore Boy and Spic and Span brands.

Personal Care Segment

Contribution margin for the Personal Care segment was up $308,000, or 14.2%, for 2007 versus 2006. The contribution margin increase was primarily the result of the sales and gross profit increase previously discussed.

General and Administrative

General and administrative expenses were $7.6 million for 2007 versus $6.4 million for 2006. The increase was primarily related to higher stock based compensation and legal costs.

Depreciation and Amortization

Depreciation and amortization expense was $2.8 million for 2007 versus $2.4 million for 2006. The increase in amortization of intangible assets is related to the Wartner acquisition, which was partially offset by a slight reduction in depreciation expense.

Interest Expense

Net interest expense was $9.7 million for 2007 versus $9.8 million for 2006. The reduction in interest expenses was the result of a lower level of indebtedness partially offset by higher interest rates on our variable rate indebtedness. The average cost of funds increased from 7.9% for 2006 to 8.5% for 2007.

Income Taxes

The income tax provision for 2007 was $5.1 million, with an effective rate of 38.0%, compared to $5.3 million, with an effective rate of 39.1% for 2006. During the fiscal year ended March 31, 2007, the Company implemented various initiatives to obtain operational, as well as tax, efficiencies.

-25-

Liquidity and Capital Resources

Liquidity

We have financed and expect to continue to finance our operations with a combination of internally generated funds and borrowings. Pursuant to the terms of the Senior Credit Facility, we may borrow an additional $200.0 million under our Tranche B Term Loan Facility and up to a maximum of $60.0 million under our Revolving Credit Facility. Our principal uses of cash are for operating expenses, debt service, acquisitions, working capital and capital expenditures.

	Three Months Ended June 30
*(In thousands)*	2007		2006
Cash provided by (used for):
Operating Activities	$	8,408	$	21,495